The search for clinically effective antivirals against the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is ongoing. Repurposing of drugs licensed for non–coronavirus disease 2019 (COVID-19) indications has been extensively investigated in laboratory models and in clinical studies with mixed results. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2022
• August 2022

The global disruption of the COVID-19 pandemic has impacted the life of every child either directly or indirectly. This review explores the pathophysiology, immune response, clinical presentation and treatment of COVID-19 in children, summarising the most up-to-date data including recent developments regarding variants of concern. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2022
• January 2022

Child maltreatment allegation is common in children following a maternal hospitalisation for assault ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2019
• September 2019

The Australian National Healthy Skin Guideline summarises evidence-based treatment of impetigo, scabies and fungal infections in high burden settings ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2020
• March 2020

The IDEA system is a valuable resource to address the needs of people living with intellectual disability ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2019
• October 2019

The aim of this study is to identify and quantify the preferences of patients with cystic fibrosis regarding treatment outcomes ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2019
• August 2019

We have undertaken to validating the specificity of commercially available antibodies marketed for flow cytometry to measure PKCα, βI, βII, δ, ε, η, θ, ζ, ι/λ and μ ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2019
• June 2019

Advances in understanding bacterial dynamics in the upper airway microbiome are driving development of microbiota-modifying therapies to prevent or treat disease ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2020
• March 2020

This review will discuss the necessary steps required for a Bayesian adaptive platform trial to optimize treatment of pulmonary exacerbations of cystic fibrosis ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2019
• March 2019

Protease elastase exocytosis by airway neutrophils occurs in all cystic fibrosis children, and its cellular measure correlates with early lung damage ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2019
• April 2019

Conception within 12 months of a stillbirth was common and was not associated with increased risk of adverse outcomes in the subsequent pregnancy ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2019
• April 2019

The epidemiology and clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are different in children and adolescents compared with adults. Although coronavirus disease 2019 (COVID-19) appears to be less common in children, with milder disease overall, severe complications may occur, including paediatric inflammatory multisystem syndrome. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2021
• October 2021